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Abstract. The trial conducted in 2007-2008, assesses the importance of anticoccidial
vaccination on groups of future layer chicken (during 64 weeks) compared to the incorporation of
Semduramycine in the food. 04 buildings of 8500 subjects each, and taken to the same (02 buildings
where vaccinated  receiving free food and anticoccidial, 02 buildings have not been vaccinated but fed
a supplemented Semduramycine). The zoological technical parameters (Consumed, laying rate and
uniformity) and parasitological (lesion score) are more profitable in vaccinees.
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INTRODUCTION
There are no farms without coccidian which are mostly found where poultry are
raised. They can take many forms and exist in the world and in any type of poultry farming
[21]. They have an economic impact estimated at two billion dollars per year, including
mortality (6-10%), the cons-performance (decreased weight gain, increased feed conversion,
decommissioning to the slaughter, poor homogeneity) and the cost of prevention and
treatment [12]. The etiologic agents are protozo, a specific parasite of the epithelial cells of
the gut, coccidia of the genus Eimeria that infect seven species of chickens [21]. Whatever the
type of farming (industrial, biological or label), the fight against coccidia is a problem of
rearing broiler future layers chicken [1]. The coccidiostats, ionophores or synthetic products
added to food (food additives), have enabled the development of poultry farming. After more
than 50 years of use, resistance emerged and new concerns emerge such as food safety and
consumer safety [12]. The restrictions of the European Union for a generation without
antibiotics led to the abandonment of research for new molecules but have stimulated the
search for new alternatives, more natural, able to reduce infection, strengthen the defenses of
the host by stimulating the immune system, assist in the healing and repair of damage caused
by the parasite. Among the new strategies, vaccination is an ideal alternative to
chemotherapy. For Vienot [14], thanks to vaccination, not only are protected poultry against
coccidiosis, but performance in livestock are equivalent or even superior to those receiving
lots of anticoccidial in their diet. This preventive approach is new  in Algeria since the
emergence of the phenomenon of "wear" met not only with anticoccidial synthesis but also
with ionophores.
In order to effectively prevent the occurrence of coccidiosis in poultry farming, the
aim of this study is to compare the effects of vaccination with a coccidiostat ionophore widely
used in continuous feed,  in future layers pullets. This comparison is based on the assessment
of animal performance (number of deaths, rate of lay and rate of homogeneity) and the lesion
index between the two lots.
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MATERIAL AND METHODS
Animals: The chickens are raised in future layers of modern buildings (Tadjenanet-
Setif), from chicks born in the hatchery of Orava (Poultry East Regional Office).
Treatment: The total workforce is 34,000 subjects, distributed in 04 buildings of 8500
subjects each, reared strictly under the same conditions and subdivided into 02 lots of
02buildings:
- Buildings 1 and 2 for unvaccinated animals (NV) and receiving a diet with an anticoccidial
continuously (Semduramycine)
- Buildings 3 and 4 for the vaccinated animals (V), receiving a diet without anticoccidial.
The vaccination protocol used Paracoxi-8 ®, a live attenuated vaccine, based on early
stem major species of coccidia. It is deposited in surface water drinking in a single
administration, between the 5th and 9th day of age, at a dose of 0.1 ml per chick. The animals
are hungry two hours before vaccination. It is prohibited to use anticoccidial drug or
anticoccidial effect throughout the life of birds.
Procedures: Two types of comparative parameters have been recorded since the date
of inception until the reform of animals:
Zootechnical parameters: Each week for 64 weeks, mortality, the rate of entry into
uniformity with the egg (¹) and laying rate were recorded.
Parasitological Parameters: Evaluation of lesions of coccidiosis (²).
¹Uniformity (score 0-4): 0 = Mixed, 1 = little homogeneous, 2 = Moderate homogeneous
Homogeneous 3 =, 4 = very homogeneous.
² lesion scores (Johnson & Reid): 0 = No lesions, 1 = minor lesions, 2 = extensive lesions, 3 =
large lesions, 4 = very significant injuries.
¹ - The rate of homogeneity is calculated by randomly weighing 50-100 subjects each
building.
It makes a mark in weight to + and - 10% of average weight. There are animals that
fall within that range. Then, we calculate the percentage that these animals are compared to
the total. This parameter has two advantages: it ensures a better rate of egg production and
increases the value of chickens to reform.
² - The intestines are held in a location with adequate lighting. The severity of lesions
of the digestive system is directly related to the intensity of infection by coccidia. These
lesions are specific to each species of coccidia. Described by Reid and Johnson [9.6] for the
diagnosis of chicken coccidiosis (E. acervulina, E. brunetti, E. maxima, E. necatrix, E. tenella)
are rated from 0-4: zero for no injury and four the highest.
Statistical methods: Statistical analysis was performed by calculating variance
(ANOVA) which allows us to deduce the standard deviations (square root of variance).
RESULTS AND DISCUSSION
Prior to entering the laying (S0 to S19): Although there were fewer deaths in the
vaccine batch (4.9%) than in the unvaccinated Lot (6.05%), the overall mortality rates remain
relatively high. Uniformity looks better for batch vaccinated (81%) than for unvaccinated lot,
but small compared to the standard required (95%) (Table 1). The amount of food consumed
before the transfer of subjects to buildings lay at the 18th week (Table 2) show an increase of
4.9 quintals Profit lots of animals vaccinated. Subjects who received the food consumed with
an anticoccidial 1160.1 1155.2 quintals cons for vaccinated animals.
Global (S0 - S64): The same parameters (Table 1) are recorded in (Tables 3,4) but for the
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entire breeding cycle (64 weeks). The differences tend to benefit the lot vaccinated, is
confirmed for both mortality rates than the rates of consistency lots, without being
significantly different.
Laying rate: The rate of egg weekly show a slight advantage for vaccinated buildings
with values respectively of 64.4% (Bt 03) and 62.4% (Bt 04) against 64% (Bt 01) and 62 %
(Bt 02), a different way by building the order of 0.4% (Table 5).
Parameter parasitology: lesion score of Johnson and Reid (Day/42): The autopsies
were performed on the 42nd day of rearing on samples of three subjects per building.
Coccidial lesions are observed only on a few subjects from receiving lots of anticoccidial
continuously in the food. The index lesion did not note + 1 an exasperated, and the lesion
score means (SLM) are very low (0.08 and 0.16 respectively for buildings 01 and 02. These
lesions are due to coccidial species caecal (E. tenella) and the posterior intestine (E. brunetti).
The table recapitulates all registered breeding parameters. Productivity gains are for all these
parameters significantly the characteristic of Lots of animals vaccinated.
Economic value of vaccination: Vaccination has benefited the production gains
(0.6% on mortality and 0.5% on rates of oviposition). Without the figures, we could not
deduce the expenses related to the therapeutic use of anticoccidial preventive and healing.
- Reduction of 0.6% mortality: 45 x 1.000 = 45 000 AD * **
- Gain an egg / hen on egg-laying cycle: 0.5 x 17 000 = 8500 eggs = 5950 chicks (≈ 70
% hatchability) = 5950 chicks x 45 AD = 267.750 AD
- Save costs of medical treatment: 20.000 AD
- Global Gains
Gain = 45,000 + 267,750 + 20,000 = 332,750 AD
Immunization expenses = 16,000 x 17 = 272 000 A D
Net earnings * = 332750-272000 = 60750 AD
(* = Price of a chick = 1.000 AD / * * 1 Euro = 100 AD (Algerian Dinar)
The mortalities recorded during the 64 weeks of rearing, are less severe in vaccinated
chickens than among those receiving the anticoccidial continuously in the food. The mortality
of 2160 against 2207 makes a difference of 47 animals (0.6%). Virtually, all field studies
show a better protection against coccidiosis (low mortality rate and improves the integrity of
the intestinal mucosa) at the vaccination than during chemotherapy based anticoccidial
(Monensin, salinomycin, Nicarbazin, Halofuginone ) in the food [4, 2, 10, 13, 18, 17, 16].
However, although the number of deaths was not statistically significant, it is nevertheless
apparent in productivity. Some statistical studies have shown that the financial gain in the
adoption of a vaccination program, compared to the continuous integration (or "shuttle") of an
anticoccidial in food [8]. Depending Champagne [2], the production costs should include not
only the fixed costs (depreciation on investments, fees on loans, insurance and payroll taxes)
and variable costs (heating, veterinary expenses and management of disinfection, Water,
Electricity, Abductions) but also the cost of feed, chicks and laborers. We have considered in
our calculations that the gains in livestock production which we have deduced the cost of
vaccination (assuming, with the exception of food, other expenses being equal). The vaccine
has an overall net profit of 600 €. In addition, lots of animals vaccinated before their transfer
to the 18 th week of entry into eggs, consumed less food (Difference = 4.9quintaux). The
score of the homogeneity of the batch is different between vaccinated animals (81%) and
animals receiving the anticoccidial (80%). The improvement (1%) is particularly noticeable
with age. Field research [18, 17, 12] are unanimous in giving greater homogeneity chickens
vaccinated phenomenon particularly visible runout. This is a significant capital gain on the
sale of chickens to reform. Finally, by monitoring animal weight, there is a difference of 120g
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for the benefit of subjects of buildings 01 and 02 (unvaccinated), whereas those of the
buildings 03 and 04 (recipients) have a body weight within the standards required by Modern
farming techniques. Overweight is proved detrimental to egg production.
Although the lesion score is almost zero (vaccinees) or very low (unvaccinated), the
parasite load does not seem great. However, vaccination confers greater protection against the
risk of infections that coccidial chemotherapy [4, 3.10, 15,16, 17, 19, 18]. Moreover, some
writers are comparable [21, 7, 11]. Vaccination has improved slightly laying rate (0.4%) and
hatchability (1%). It is obvious that protected animals against coccidian parasitism, enhance
and optimize their metabolism production.
Table 1:
Mortality Weekly and consistency before entry into the egg (S0 to S19) .
Mortality (%) Score Homogeneity
Building Cumulative / Btt Proportion Average / Lot Injury) Rate Medium
01  (N.V) 536 6,3 6,05 2,8 77 78,5
02  (N.V) 495 5,8 3 79,9
03   (V) 470 5,5 4,9 2,9 81 81
04   (V) 369 4,3 3,2 81
Table 2:
Total quantity of food consumed depending on the batch.
Quantity of Food Consumed Treatment groups Aviax ® Lots Vaccinated Paracoxi-8 ®
Before the transfer (18th week) 1160,1 q 1155,2 q
Difference 4,9 q
* NV = not vaccinated animals (receiving the ATC in the food V = vaccinated animals. Anticoccidial = ATC.).
Table 3 :
Mortality rate and homogeneity throughout the rearing cycle
FINAL RESULTS
S0 to S 64 Building
Mortality HomogeneityClutch
Number % Score (%) Rate
Animals receiving ATC
01 1210 14.2 2,90
(78.5%)
64%
02 1096 12.9 62%
Vaccinated 03 1133 13.3 3,05 (81%)
64.4%
04 1024 12 62.4%
Table 4:





Homogeneity Rate Clutch Rate Hatching
unvaccinated 2207 26% 2,90 (78.5%) 63% 80%
Vaccinated 2160 25,4% 3,05 (81%) 63.4% 81%
Difference 47 0,6% 0.15 (2.5%) 0.4% 1%
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Table 5:
Rate of lay depending on the premises
Building UNV-1 UNV-2 V-3 V-4
Medium 64% 62% 64,40% 62,40%
UNV = unvaccinated, V = Vaccinated.
CONCLUSIONS
At the multiplication of ‘organic’, the ban on additives in feeding animals (Naciri,
2001), globalization and chicken production quality and lowest price vaccination is a
prophylactic measure innovative and interesting for the poultry industry. It has, in addition to
animal performance, other benefits, such as the absence of residues in carcasses and eggs,
lack of chemo resistance [Naciri, 2001; Vienot, 2005] and the presence of the phenomenon of
"Recycling" which can reduce the parasite load of litter and reduce the risk of sudden
infestation of chickens. Maintaining such a litter provides virtually no risk of development of
coccidiosis [Lunden et al, 2003; Waldenstedt et al, 1999; Williams, 1994; 1998]. The use of
the vaccine (Paracoxi-8 ®) in protection against avian coccidiosis has shown some
advantages compared to livestock continuous use of an anticoccidial ionophore
(Senduramycine) in the food. A single vaccine can protect the animal throughout its life. In
Algeria, when coccidiosis is still a problem recurring disease of poultry farms, widespread
vaccination is facing a "resistance" tough followers of the chemotherapy.
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